Premium
Inadequate growth hormone suppression following an octreotide test dose predicts the need for adjuvant therapy to achieve ‘safe’ growth hormone levels
Author(s) -
Lindsay John R.,
Atkinson A. Brew
Publication year - 2006
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/j.1365-2265.2006.02480.x
Subject(s) - medicine , citation , diabetes mellitus , growth hormone , endocrinology , octreotide , test (biology) , hormone , library science , somatostatin , biology , computer science , paleontology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom